Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 5/2014

Open Access 01-10-2014 | Letter

Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief

Authors: Pietro Caironi, Luciano Gattinoni

Published in: Critical Care | Issue 5/2014

Login to get access

Abstract

No abstract.
Literature
1.
Flannery AH, Kane SP, Coz-Yataco AO: A word of caution regarding proposed benefits of albumin from ALBIOS: a dose of healthy skepticism. Crit Care. 2014, 18: 509-10.1186/s13054-014-0509-x.PubMedCentralCrossRef
2.
Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L: Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014, 370: 1412-1421. 10.1056/NEJMoa1305727.CrossRef
3.
Quinlan GJ, Martin GS, Evans TW: Albumin: biochemical properties and therapeutic potential. Hepatology. 2005, 41: 1211-1219. 10.1002/hep.20720.CrossRef
4.
Caironi P, Gattinoni L: The clinical use of albumin: the point of view of a specialist in intensive care. Blood Transfus. 2009, 7: 259-267.PubMedCentral
5.
O’Brien AJ, Fullerton JN, Massey KA, Auld G, Sewell G, James S, Newson J, Karra E, Winstanley A, Alazawi W, Garcia-Martinez R, Cordoba J, Nicolaou A, Gilroy DW: Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. Nat Med. 2014, 20: 518-523. 10.1038/nm.3516.CrossRef
6.
Caironi P, Tognoni G, Gattinoni L: Albumin replacement in severe sepsis or septic shock. N Engl J Med. 2014, 371: 84-10.1056/NEJMc1405198.CrossRef
Metadata
Title
Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief
Authors
Pietro Caironi
Luciano Gattinoni
Publication date
01-10-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-014-0510-4

Other articles of this Issue 5/2014

Critical Care 5/2014 Go to the issue

Research

Platelet aggregation and clot formation in comatose survivors of cardiac arrest treated with induced hypothermia and dual platelet inhibition with aspirin and ticagrelor; a prospective observational study

Review

Antibiotic stewardship in the intensive care unit

Review

Sepsis-associated hyperlactatemia

Research

Seventy-two hours of mild hypothermia after cardiac arrest is associated with a lowered inflammatory response during rewarming in a prospective observational study

Research

Psychometric comparison of three behavioural scales for the assessment of pain in critically ill patients unable to self-report

Research

Early versus delayed administration of norepinephrine in patients with septic shock